AbbVie wraps up $63bn acquisition of Irish drugmaker Allergan
US biopharma company AbbVie has wrapped up its previously announced $63 billion acquisition of Irish drugmaker Allergan following receipt of all the required approvals from all government authorities and approval from the Irish High Court. AbbVie acquisition of Allergan, which was announced in June 2019, is said to expand and diversify significantly the former’s revenue […]
AbbVie acquisition of Allergan update : US biopharma company AbbVie has secured clearance from the US Federal Trade Commission (FTC) for its previously announced $63 billion acquisition of Botox developer Allergan. According to AbbVie, the approval from the FTC satisfies all the necessary antitrust clearances required for the closing of the cash cum stock deal […]
Continue reading …
Allergan has agreed to sell IL-23 inhibitor brazikumab to AstraZeneca and gastrointestinal medication Zenpep (pancrelipase) to Nestle in separate agreements, as per the latest pharma acquisition news. Financial details of the two deals have not been disclosed. The divestments are being taken up in an effort to wrap up the $63 billion AbbVie acquisition of […]
Continue reading …
Ubrelvy FDA approval : Irish pharma company Allergan has bagged approval from the US Food and Drug Administration (FDA) for Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura in adults. Aura is a sensory phenomenon or visual disturbance. Ubrelvy is now the first orally-administered calcitonin gene-related peptide (CGRP) receptor […]
Continue reading …
Rituxan biosimilar ABP 798 : US biopharma company Amgen and Irish pharma company Allergan have submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for ABP 798, a biosimilar candidate to Roche’s cancer drug Rituxan (rituximab). Rituxan, which is a CD20-directed cytolytic antibody, has approval across various regions for the […]
Continue reading …
AbbVie acquisition of Allergan : US biopharma company AbbVie is all set to acquire Botox developer Allergan, an Irish pharma company, for $63 billion in a cash cum stock deal, as per pharma acquisition news. Headquartered in Chicago, AbbVie is engaged in developing drugs in areas such as immunology, oncology, neuroscience, and virology. On the […]
Continue reading …
Spanish pharma company Almirall has completed its $550 million acquisition of five skin medications from Allergan’s Medical Dermatology unit in the US. The skin medications acquired by Almirall, as part of a deal signed in August 2018, are acne and dermatoses brands Aczone (dapsone), Tazorac (tazarotene), Cordran Tape (flurandrenolide), Azelex (azelaic acid). Along with them, […]
Continue reading …Allergan acquisition of Bonti : Allergan to acquire US aesthetic company in $195m deal
September 16, 2018 No Comment
Allergan acquisition of Bonti : Irish pharma company Allergan will acquire Bonti, a US aesthetic company, engaged in the development of fast-acting neurotoxin programs for aesthetic and therapeutic applications, in a deal worth over $195 million. Allergan Acquisition of Bonti | US Aesthetic Company in $195m Deal As per the terms of the Allergan acquisition […]
Continue reading …
Business News Today
- HDFC Bank, CSC launch EMI collection services for business correspondents
- PNC Bank to acquire payment gateway provider Tempus Technologies
- US insurtech company Joshu raises $3.7m in seed round
- Nordic Capital offers to acquire Advanz Pharma for $846m
- Aditya Birla unit to acquire stake in designer brand Sabyasachi
- PepsiCo, Beyond Meat create JV for plant-based snacks and beverages
- Surrey Bank & Trust to sell SB&T Insurance to Mountcastle Insurance
- NCR to acquire ATM operator Cardtronics for $2.5bn
- Twitter acquires email newsletter startup Revue
- Eni wins P2511 licence in 32nd UK Offshore Licensing Round
